News
It is with great sadness that we announce the passing of Mr. Jeff Courtney, Board of Directors and Finance and Audit Committee member....
ENDRA Life Sciences Inc., a developer of enhanced ultrasound technologies, has contracted with CIMTEC, a leading contract research...
A new study published by CIMTEC client Proteocyte provides further data showing Straticyte offers better predictive insight over...
TORONTO, ON − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the “Company” or “3DS”), is pleased to announce that the clinical trial...
TORONTO--(BUSINESS WIRE)--KalGene Pharmaceuticals Inc., in collaboration with the National Research Council of Canada (NRC), CIMTEC and the...
3D Signatures (TSX Venture: DXD.V; OTCQB: TDSGF; Frankfurt: 3DO) is a medical imaging company that is developing diagnostic tools based on...
CIMTEC spin-off NeoVision was founded to commercialize the neonatal brain imaging technology derived from Dr. Aaron Fenster's research at...
UPDATE AS OF FRIDAY MARCH 17TH 4:00PM IMPORTANT - DEADLINE EXTENDED TO TUESDAY MARCH 21ST! 2017 OBI ONtrepreneurs Program Application...
Ontario’s wealth of cancer research expertise is not limited to one city or region. Innovations from researchers and clinician-scientists...
FedDev Ontario Invests $1.32 Million to Support 30 Companies and Create Jobs News Release From Federal Economic Development Agency for...
